<?xml version="1.0" encoding="UTF-8"?>
<p>A set of sensitivity analyses were undertaken. Analyses were repeated restricting to patients with documented or presumed heterosexual transmission, patients starting ART post2004, cohorts with more than 50% of data on CD4
 <sup>+</sup> cell counts at baseline and cohorts with ‘very good’ self-reported mortality ascertainment.
</p>
